Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice

Topic: Inflammation, microglia and astrocytes

Background Amyloid-related imaging abnormalities (ARIA) have been identified as the most common and serious adverse events resulting from pathological changes in the cerebral vasculature during several recent anti-amyloid-β (Aβ) immunotherapy trials. However, the precise cellular and molecular mechanisms underlying how amyloid immunotherapy enhances cerebral amyloid angiopathy (CAA)-mediated alterations in vascular permeability and microhemorrhages are not currently understood. Interestingly, brain perivascular macrophages have been implicated in regulating CAA deposition and cerebrovascular function however, further investigations are required to understand how perivascular macrophages play a role in enhancing CAA-related vascular permeability and microhemorrhages associated with amyloid immunotherapy. Methods In this study, we examined immune responses induced by amyloid-targeting antibodies and CAA-induced microhemorrhages using histology and gene expression analyses in Alzheimer's disease (AD) mouse models and primary culture systems. Results In the present study, we demonstrate that anti-Aβ (3D6) immunotherapy leads to the formation of an antibody immune complex with vascular amyloid deposits and induces the activation of CD169 + perivascular macrophages. We show that macrophages activated by antibody mediated Fc receptor signaling have increased expression of inflammatory signaling and extracellular matrix remodeling genes such as Timp1 and MMP9 in vitro and confirm these key findings in vivo. Finally, we demonstrate enhanced vascular permeability of plasma proteins and recruitment of inflammatory monocytes around vascular amyloid deposits, which are associated with hemosiderin deposits from cerebral microhemorrhages, suggesting the multidimensional roles of activated perivascular macrophages in response to Aβ immunotherapy. Conclusions In summary, our study establishes a connection between Aβ antibodies engaged at CAA deposits, the activation of perivascular macrophages, and the upregulation of genes involved in vascular permeability. However, the implications of this phenomenon on the susceptibility to microhemorrhages remain to be fully elucidated. Further investigations are warranted to determine the precise role of CD169 + perivascular macrophages in enhancing CAA-mediated vascular permeability, extravasation of plasma proteins, and infiltration of immune cells associated with microhemorrhages.

Key findings

• Interestingly, brain perivascular macrophages have been implicated in regulating CAA deposition and cerebrovascular function however, further investigations are required to understand how perivascular macrophages play a role in enhancing CAA-related vascular permeability and microhemorrhages associated with amyloid immunotherapy.
• Results In the present study, we demonstrate that anti-Aβ (3D6) immunotherapy leads to the formation of an antibody immune complex with vascular amyloid deposits and induces the activation of CD169 + perivascular macrophages.
• Finally, we demonstrate enhanced vascular permeability of plasma proteins and recruitment of inflammatory monocytes around vascular amyloid deposits, which are associated with hemosiderin deposits from cerebral microhemorrhages, suggesting the multidimensional roles of activated perivascular macrophages in response to Aβ immunotherapy.
• Further investigations are warranted to determine the precise role of CD169 + perivascular macrophages in enhancing CAA-mediated vascular permeability, extravasation of plasma proteins, and infiltration of immune cells associated with microhemorrhages.

New to this subject? Start with our plain-English guide: Treatments →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1186/s13024-023-00649-w
• PubMed: 37649100
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{taylor2023-37649100,
  author  = {Taylor, X. and Clark, I. M. and Fitzgerald, G. J. and Oluoch, H. and Hole, J. T. and DeMattos, R. B. and Wang, Y. and Pan, F.},
  title   = {{Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice}},
  journal = {Molecular neurodegeneration},
  year    = {2023},
  doi     = {10.1186/s13024-023-00649-w},
  pmid    = {37649100},
  url     = {https://doi.org/10.1186/s13024-023-00649-w}
}

Related studies in Treatments

• Amyloid-β (Aβ) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer's disease Molecular neurodegeneration · 2024-10-21 · usefulness score 45/100
• Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress Molecular neurodegeneration · 2023-10-03 · usefulness score 41/100
• Anti-amyloid immunotherapy drives APOE4 specific increases in glial reactivity, perivascular immune activation, and ARIA-like events bioRxiv · 2026-06-29 · usefulness score 16/100
• Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction Brain research · 1996-01-01 · usefulness score 36/100
• Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013-04-11 · usefulness score 43/100
• Intravenous anti-Aβ immunotherapy acutely increases cerebral amyloid angiopathy and vascular damages in APOE4 mice bioRxiv · 2026-02-11 · usefulness score 16/100

Also tagged “amyloid-angiopathy”

229 studies in the library carry the topic tag “amyloid-angiopathy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 229 tagged studies.

• Dysfunction of the Blood-brain Barrier in Cerebral Microbleeds: from Bedside to Bench Aging and disease · 2021-12-01 · usefulness score 41/100 · Vascular contributions
• Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia International journal of molecular sciences · 2020-01-20 · usefulness score 39/100 · Vascular contributions

Similar studies

• Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice 2026 · Treatments
• Transcriptomic Profile of Blood-Brain Barrier Remodeling in Cerebral Amyloid Angiopathy 2022 · Vascular contributions
• The role of neuroinflammation in cerebral amyloid angiopathy 2024 · Treatments
• Inflammation in Alzheimer’s disease: insights from immunotherapy 2013 · Treatments
• The blood-brain barrier in Alzheimer's disease 2017 · Vascular contributions
• Effects of cerebral amyloid angiopathy on the brain vasculome 2022 · Vascular contributions

More on Treatments

• A review that covers this ground Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy Frontiers in radiology · 2024-01-05 · usefulness score 41/100
• Newest in this subject Opposing Regulation of Tau Condensation by Phosphorylation Levels and Molecular Chaperone Interactions bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Natural Sesquiterpenoids from Laggera pterodonta as bioactive Acetylcholinesterase Inhibitors: Insights from DFT, Molecular Docking, and ADMET Profiling Research Square · 2026-10-20 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Treatments →